OQROSign up free
Insider trade

Cytokinetics (CYTK): Director sold ~$141K

B Lynne Parshall, Director at Cytokinetics, sold ~$141K of Cytokinetics shares.

~$141K
Approx. value · 2,555 sh @ $55.26
5,784
Holds after · shares reported
Traded
Nov 9, 2026
Filed
Nov 12, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 11, 2026InsiderDirector sold ~$75K of CYTK shares in the open market
  2. Sep 14, 2026InsiderCEO sold ~$551K of CYTK shares in the open market
  3. Sep 15, 2026Insider · 2 peopleInsiders: 2 sales (~$6.9M)
  4. Sep 22, 2026InsiderOfficer sold ~$239K of CYTK shares in the open market
  5. Sep 28, 2026InsiderCEO sold ~$491K of CYTK shares in the open market
  6. Sep 29, 2026CongressDisclosed purchase of CYTK — reported range $1,001 - $15,000
  7. Oct 6, 2026InsiderOfficer sold ~$215K of CYTK shares in the open market
  8. Oct 12, 2026InsiderCEO sold ~$472K of CYTK shares in the open market
  9. Oct 20, 2026InsiderOfficer sold ~$224K of CYTK shares in the open market
  10. Nov 2, 2026InsiderCEO sold ~$471K of CYTK shares in the open market
  11. Nov 3, 2026InsiderOfficer sold ~$220K of CYTK shares in the open market
  12. Nov 4, 2026Company filing · Form 8-K · ResultsReported its results
  13. Nov 9, 2026 · this disclosureInsiderDirector sold ~$141K of CYTK shares in the open market

What came next

  1. Nov 9, 2026InsiderDirector sold ~$132K of CYTK shares in the open market
  2. Nov 10, 20265% stakeSTATE STREET CORPORATION reported a passive stake (13G) of 5.1%
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Cytokinetics

For Cytokinetics, OQRO holds 21 insider filings (SEC Form 4 or Form 144) and 1 Congress trade report dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CYTK page.

Other recent filings by B Lynne Parshall, Director

The full history of B Lynne Parshall, Director is on the profile page.

How this filing works

Explore the data

Other disclosures at Cytokinetics

Everything OQRO holds on this company is on its CYTK page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Sign up freeAlready have an account? Log in

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data